Intraocular Pressure Control After Anterior Segment Laser - Comparison Between 2 Drugs
Information source: Universidade Federal do Paraná
ClinicalTrials.gov processed this data on August 20, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Glaucoma, Narrow Angle
Intervention: YAG laser peripheral iridotomy (Procedure); YAG laser peripheral iridotomy (Procedure)
Phase: N/A
Status: Recruiting
Sponsored by: Universidade Federal do Paraná Official(s) and/or principal investigator(s): Lucas Shiokawa, MD, Principal Investigator, Affiliation: Universidade Federal do Parana
Overall contact: Lucas Shiokawa, MD, Phone: 55 41 91432398, Email: lucasshiokawa@yahoo.com.br
Summary
The purpose of this study is to compare the intra-ocular (IOP) control efficacy between
brimonidine 0. 1% vs. 0. 2% after laser peripheral iridotomy (LPI).
Clinical Details
Official title: Short-term Intraocular Pressure Control After YAG Iridotomy - Comparison Between Brimonidine 0.1% vs. 0.2%
Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Prevention
Primary outcome: intra-ocular pressure increase
Detailed description:
Postoperative IOP elevation is one of the most common complications after LPI. Previous
studies showed that brimonidine 0. 2% is effective in blunting IOP spikes after LPI. This
prospective randomized double-masked interventional study will include patients with
bilateral narrow angles, defined by irido-trabecular contact in >180o on
gonioscopy. Pilocarpine 1% will be used in both eyes, and 30 minutes later, brimonidine 0. 1%
randomly used in one eye and brimonidine 0. 2% in the contra-lateral eye. LPI with Nd: YAG
laser is performed 30 minutes later in both eyes by a single glaucoma specialist. IOP
measurements are assessed before the use of any eyedrop (basal IOP), 30 minutes after
pilocarpine (pre-brimonidine), and 30, 60, 120, 180 minutes after LPI. Pachymetry,
ultrasonic biometry, gonioscopy, and total YAG laser energy are recorded. Non-parametric
test will be used for analysis.
Eligibility
Minimum age: 40 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- bilateral narrow angles, defined by irido-trabecular contact in >180o on gonioscopy
Exclusion Criteria:
- previous cataract surgery
Locations and Contacts
Lucas Shiokawa, MD, Phone: 55 41 91432398, Email: lucasshiokawa@yahoo.com.br
Universidade Federal do Parana, Curitiba, Parana 80060-150, Brazil; Recruiting Lucas Shiokawa, Principal Investigator Lisandro Sakata, Principal Investigator Dayane Issaho, Principal Investigator
Additional Information
Related publications: Brazier DJ. Neodymium-YAG laser iridotomy. J R Soc Med. 1986 Nov;79(11):658-60. Chen TC, Ang RT, Grosskreutz CL, Pasquale LR, Fan JT. Brimonidine 0.2% versus apraclonidine 0.5% for prevention of intraocular pressure elevations after anterior segment laser surgery. Ophthalmology. 2001 Jun;108(6):1033-8. Chen TC. Brimonidine 0.15% versus apraclonidine 0.5% for prevention of intraocular pressure elevation after anterior segment laser surgery. J Cataract Refract Surg. 2005 Sep;31(9):1707-12. Drake MV. Neodymium:YAG laser iridotomy. Surv Ophthalmol. 1987 Nov-Dec;32(3):171-7. Review. Hartenbaum D, Wilson H, Maloney S, Vacarelli L, Orillac R, Sharpe E. A randomized study of dorzolamide in the prevention of elevated intraocular pressure after anterior segment laser surgery. Dorzolamide Laser Study Group. J Glaucoma. 1999 Aug;8(4):273-5. Kashiwagi K, Abe K, Tsukahara S. Quantitative evaluation of changes in anterior segment biometry by peripheral laser iridotomy using newly developed scanning peripheral anterior chamber depth analyser. Br J Ophthalmol. 2004 Aug;88(8):1036-41. Khodadoust AA, Arkfeld DF, Caprioli J, Sears ML. Ocular effect of neodymium-YAG laser. Am J Ophthalmol. 1984 Aug 15;98(2):144-52. Robin AL, Arkell S, Gilbert SM, Goossens AA, Werner RP, Korshin OM. Q-switched neodymium-YAG laser iridotomy. A field trial with a portable laser system. Arch Ophthalmol. 1986 Apr;104(4):526-30. Schrems W, Eichelbrönner O, Krieglstein GK. The immediate IOP response of Nd-YAG-laser iridotomy and its prophylactic treatability. Acta Ophthalmol (Copenh). 1984 Oct;62(5):673-80. Wetzel W. Ocular aqueous humor dynamics after photodisruptive laser surgery procedures. Ophthalmic Surg. 1994 May;25(5):298-302.
Starting date: November 2010
Last updated: August 15, 2011
|